• HC Wainwright Reiterates "Buy" Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

    Source: Buzz FX / 03 Mar 2025 08:03:14   America/Chicago


    HC Wainwright Reiterates "Buy" Rating for Apellis Pharmaceuticals (NASDAQ:APLS) Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Apellis Pharmaceuticals ( NASDAQ:APLS - Get Free Report ) 's stock had its "buy" rating reaf
    Read more...
Share on,